Close Menu

NEW YORK (GenomeWeb) – Focus Diagnostics today announced its Simplexa Group A Strep Direct kit has received 510(k) clearance from the US Food and Drug Administration for marketing in the US. 

The agency has also categorized the test as moderate complexity, which will allow some clinicians to perform the test directly. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A new analysis finds that nearly half the late-stage clinical trials sponsored by a US National Cancer Institute program influence patient care.

The owner of the GEDmatch website tells CBS12 he is considering charging law enforcement a fee to use the site.

Technology Review reports that sickle cell patients are optimistic about gene editing to treat their disease, but are worried about how available it will be.

In Nature this week: babies born by caesarean section are more likely to have altered gut microbiota profiles, and more.